International Journal of Mental Health and Addiction
May 5, 2026
Cerina Dubois, Amrit Baral, Riana Durrett et al.
An emerging approach called California Sober (CS) has gained attention for promoting abstinence of all intoxicating substances except cannabis and potentially, psychedelics. Cannabis legalization and the expansion of cannabis products have introduced new complexities in addiction recovery, challenging traditional abstinence-based frameworks such as Alcoholics Anonymous (AA), which define...
International Journal of Mental Health and Addiction
April 25, 2026
Thomas Wojciechowski
Abstract Research understanding predictors of early onset of Dextromethorphan misuse remains limited. Exposure to violence is one risk factor that may predict earlier onset of use. Racial identification may moderate this relationship. Secondary exploratory analyses of the Adolescent Brain Cognitive Development data were carried out. Cox proportional hazard models estimated the direct effect of...
International Journal of Mental Health and Addiction
March 17, 2026
Haley Maria Dourron, Melissa Bradley, Heith Copes et al.
Abstract Despite a long-standing interest in the potential similarities between psychedelic and psychotic experiences, no recent research has systematically explored the subjective overlap between these states in individuals who have experienced both. To provide rich accounts of potential overlaps and distinctions, we conducted semi-structured interviews with 19 individuals diagnosed with...
International Journal of Mental Health and Addiction
April 29, 2025
David Sjöström, Emma Claesdotter-Knutsson, Isabella Gripe et al.
It is still unknown how current trends in psychedelic use among adolescents are related to mental health. This study reports on the prevalence of psychedelic use in a Swedish representative nationwide drug survey and its association with mental health outcomes and user personality. A cross-sectional study using data from the latest 2024 Swedish Council for Information on Alcohol and Other Drugs...
International Journal of Mental Health and Addiction
April 1, 2025
Joshua C. Black, Nicole Schow, Hannah L. Burkett et al.
3 citations
Psychedelic-assisted therapy could transform treating psychiatric illness, but harms from exacerbating substance use disorder (SUD) among adults with psychiatric illness using psychedelics have not been studied. A cross-sectional survey in the US was used to test whether Drug Abuse Screening Test scores (DAST-10, validated instrument predicting SUD) were more severe when psychiatric illnesses...
International Journal of Mental Health and Addiction
April 1, 2024
Joseph T. Torre, Mehdi Mahammadli, Sonya C. Faber et al.
31 citations
Currently, individuals with personal or familial histories of psychopathological experiences of psychosis, psychotic spectrum disorders, bipolar disorder, and similar conditions are excluded from most psychedelic clinical trials, studies, and treatment programs. This study sought to determine why such an exclusion exists, what the implications of the exclusion criteria are, and if there was...
International Journal of Mental Health and Addiction
April 1, 2024
Monnica T. Williams, Victor Cabral, Sonya C. Faber
22 citations
Psychedelics are being studied for the treatment of numerous mental health disorders, as well as a means of bringing people together. Nonetheless, people of color and those with other marginalized identities have not been fully included. Studies and research on psychedelic-assisted therapies have largely excluded people of color, leaving out fundamental clinical issues for these populations....
International Journal of Mental Health and Addiction
April 1, 2024
Christine Diindiisi Mccleave, Susan Beaulieu, Rainbow Lopez et al.
9 citations
This article reflects the commentary of Indigenous experts, students, and practitioners from North America. Topics discussed include the historical context of colonialism and the Psychedelic Renaissance, duality of Spirit and science, the challenges of being an Indigenous person in psychedelic spaces, and the role of culture in healing trauma. The authors expand upon topics such as the harms...
International Journal of Mental Health and Addiction
April 1, 2024
Doris Payer, Sukhpreet Klaire, Dominique Morisano et al.
4 citations
The field of psychedelics is in an important era, with a significant focus on the potential role of psychedelic compounds in the treatment of mental health and substance use disorders. In 2022, a scientific research conference was held in Toronto to bring together stakeholders from a variety of disciplines and to promote dialogue and collaboration. This Special Issue includes 8 papers based on...
International Journal of Mental Health and Addiction
April 1, 2024
David T. Kryszajtys, Jacqueline L. Bender, Brian Rush et al.
2 citations
Little is known about how people decide to use psychedelics to self-treat depression and anxiety, though the practice is growing. We explored online community discussions of members’ decisions around self-treatment with psychedelics for depression or anxiety. We used constructivist grounded theory to select and analyze 98 members’ posts across 95 discussion threads (99, 552 words) and...
International Journal of Mental Health and Addiction
March 7, 2024
Brandon Weiss, Leor Roseman, Bruna Giribaldi et al.
26 citations
Abstract The mechanisms by which Psilocybin Therapy (PT) improves depression remain an important object of study, with scientists actively exploring acute psychological experiences and neurobiological processes as candidates. In a phase 2, double-blind, randomized, active comparator controlled trial involving patients with moderate-to-severe major depressive disorder, we investigated whether...
International Journal of Mental Health and Addiction
November 28, 2023
Tayler Holborn, Robert L. Page, Fabrizio Schifano et al.
5 citations
Abstract Currently, novel psychoactive substance (NPS) use presents a challenging issue for authorities. To effectively tackle the use of NPS, a deeper understanding of the motivations of those who use NPS is required. Evidence suggests that a subset of NPS users declare their use as ‘self-medicating’; however, there is a paucity of research in this area. The aim of this review is to provide an...
International Journal of Mental Health and Addiction
August 29, 2023
Andrea Escelsior, Alice Trabucco, M. Radicati et al.
Time perception received growing interest in psychiatry for its psychopathological implications. Cannabis use can cause a subjective experience of temporal perception alteration and increases the risk of emergence of mental illnesses such as psychotic and mood disorders. In this framework, we systematically reviewed the findings regarding the clinical, cognitive, and neurobiological correlates...